| Secondary |
| Product Used For Unknown Indication |
33.3% |
| Convulsion |
14.3% |
| Crohn's Disease |
9.5% |
| Epilepsy |
9.5% |
| Liver Transplant |
9.5% |
| Oral Candidiasis |
4.8% |
| Rheumatoid Arthritis |
4.8% |
| Blood Cholesterol |
2.4% |
| Ill-defined Disorder |
2.4% |
| Immunosuppression |
2.4% |
| Relapsing-remitting Multiple Sclerosis |
2.4% |
| Schizophrenia |
2.4% |
| Vitamin D Decreased |
2.4% |
|
| Lymphoma |
20.0% |
| Renal Function Test Abnormal |
20.0% |
| Liver Transplant Rejection |
10.0% |
| Malignant Melanoma |
10.0% |
| Thyroid Cancer |
10.0% |
| Toxic Epidermal Necrolysis |
10.0% |
| Tuberculosis |
10.0% |
| Vomiting |
10.0% |
|
| Concomitant |
| Crohn's Disease |
18.9% |
| Product Used For Unknown Indication |
13.1% |
| Nuclear Magnetic Resonance Imaging |
6.8% |
| Allogenic Bone Marrow Transplantation Therapy |
6.1% |
| Drug Use For Unknown Indication |
5.6% |
| Multiple Myeloma |
5.6% |
| Osteoporosis |
4.8% |
| Prophylaxis |
4.8% |
| Renal Failure Chronic |
4.4% |
| Renal Transplant |
4.3% |
| Rheumatoid Arthritis |
4.3% |
| Hypertension |
3.7% |
| Renal Failure |
2.7% |
| Imaging Procedure |
2.4% |
| Sleep Disorder |
2.4% |
| Haemolytic Uraemic Syndrome |
2.2% |
| Iron Overload |
2.2% |
| Graft Versus Host Disease |
2.0% |
| Diabetes Mellitus |
1.9% |
| Osteoporosis Postmenopausal |
1.9% |
|
| Crohn's Disease |
12.2% |
| Complications Of Bone Marrow Transplant |
6.7% |
| Sepsis |
6.7% |
| Coccidioidomycosis |
5.6% |
| Renal Failure |
5.6% |
| Renal Impairment |
5.6% |
| Therapeutic Response Decreased |
5.6% |
| Urine Output Decreased |
5.6% |
| Vomiting |
5.6% |
| Nephrogenic Systemic Fibrosis |
4.4% |
| Pyrexia |
4.4% |
| Respiratory Failure |
4.4% |
| Stenotrophomonas Infection |
4.4% |
| Aphasia |
3.3% |
| Death |
3.3% |
| Haemoglobin Decreased |
3.3% |
| Osteonecrosis Of Jaw |
3.3% |
| Serum Ferritin Abnormal |
3.3% |
| Thrombocytopenia |
3.3% |
| Transplant Rejection |
3.3% |
|
| Interacting |
| Drug Use For Unknown Indication |
100.0% |
|
| Lung Disorder |
50.0% |
| Lung Transplant |
50.0% |
|
